Olanzapine, formerly known as Zyprexa is a US Food and Drug administration approved drug used in the treatment of schizophrenia, bipolar disorder and other neurological disorders. Olanzapine is generic and is available under many trade names worldwide. Olanzapine is promoted in various nations, with tablets running from 2.5 to 20 milligrams. Zyprexa (and nonspecific olanzapine) is accessible as an orally-breaking down "wafer" which quickly disintegrates in spit. It is likewise accessible in 10 milligram vials for intramuscular infusion.
The market of Olanzapine has been evaluated as $XX million which includes the XX% of market share from Asia pacific followed by Europe. Olanzapine was firstly introduced in the Europe region in the year 1996 when the high amount of population was suffering from the neurological disorder diseases. China is the largest market for the Olanzapine drug and growing with the compound annual growth rate (CAGR) rate of more than 27% and expected to touch the CAGR of XX% in the forecasted period. Olanzapine has been very effective drug but it also has some negative aspects like agitation, dysarthria with others.
Global Olanzapine Market Report: Market Segmentation
For the better understanding of the topic, Global Olanzapine market report has been segmented on the basis of:
· Types
· Application
· Geography
Types of Olanzapine is been categorized as ZYPREXA tablets, ZYPREXA ZYDIS and ZYPREXA IntraMuscular which is available for injections. Olanzapine applications includes (Schizophrenia, Bipolar disorder, among others)
Global Olanzapine Market Report: Key Players
The key player in the global Olanzapine market includes: